{"schema_version":"secwatch.filing_event.v1","accession":"0001793229-26-000077","form_type":"8-K","ticker":"CTEV","cik":"0001793229","company_name":"Claritev Corp","filed_at":"2026-10-15T13:03:37+00:00","discovered_at":"2026-10-15T13:05:00.263496+00:00","generated_at":"2026-10-15T13:05:03.557055+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Claritev adds Jennifer Main to board; ex-CMS COO and TARP CFO takes new Class II seat","bullets":["Board expanded from 11 to 12 directors; Main appointed to the newly created Class II directorship effective October 15, 2026, and joins the Audit Committee.","Concurrently, Mr. Jason Kap ceased serving as a member of the Audit Committee; no other committee changes disclosed.","Main is CFO of RealMDai (dba Certuma) and Overture Life since March 2026; previously CFO and COO of Amalgam Rx from 2021 to 2026.","She was Chief Operating Officer of the Centers for Medicare & Medicaid Services from 2018 to 2021, overseeing Medicare, Medicaid and marketplace programs, and CFO of Treasury's $700 billion TARP.","Compensation follows the non-employee director policy in the March 20, 2026 proxy; she will enter the company's standard indemnification agreement. No related-party transactions disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001793229-26-000077","json":"https://secwatch.observer/filing/0001793229-26-000077.json","markdown":"https://secwatch.observer/filing/0001793229-26-000077.md","text":"https://secwatch.observer/filing/0001793229-26-000077.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1793229/000179322926000077/0001793229-26-000077-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1793229/000179322926000077/ctev-20261015.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-15T13:05:03.557055+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5f69271059","claim":"Jennifer Main was appointed as Class II director at Claritev Corp.","evidence_excerpt":"Effective as of the Effective Date, the Board appointed Ms. Jennifer Main to fill the newly created directorship, to serve as a Class II director and a member of the Audit Committee.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1793229/000179322926000077/0001793229-26-000077-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}